News
-
-
PRESS RELEASE
Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt
Tryp Therapeutics, Inc. announces shareholder approval and completion of plan of arrangement with Exopharm Limited. Anticipates trading on ASX as Tryptamine Therapeutics Limited (ticker symbol TYP) in May 2024 -
-
-
-
-
PRESS RELEASE
TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare
TVM Capital Healthcare invests EUR 16 million in neurocare group AG to support growth plans, including MENA region expansion. neurocare offers personalized mental health care with innovative neurostimulation methods and digital therapy platform -
PRESS RELEASE
NeuroNexus is Leveraging Bioz's AI-Powered Citation Tools to Drive Increased Sales Conversion
Bioz, Inc. partners with NeuroNexus to offer digital citation widgets displaying product mentions. Bioz utilizes NLP and ML for analyzing scientific literature. NeuroNexus develops neural interface tech for neuroscience research -
-